{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:09:46Z","timestamp":1790561386144,"version":"4.1.0"},"reference-count":41,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006419","name":"EuroQol Foundation","doi-asserted-by":"crossref","award":["1456-PD"],"award-info":[{"award-number":["1456-PD"]}],"id":[{"id":"10.13039\/501100006419","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Alternative Funding Plan from the Academic Health Sciences Centres of Ontario","award":["SHS-20-020"],"award-info":[{"award-number":["SHS-20-020"]}]},{"DOI":"10.13039\/100012659","name":"Canadian Centre for Applied Research in Cancer Control","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Canadian Partnership Against Cancer Corporation and Health Canada","award":["13283"],"award-info":[{"award-number":["13283"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Background: EQ-5D-3L health utilities inform health technology assessments in oncology, often derived from clinical trials enrolling highly selected populations, which may over-estimate real-world health utilities. Little is known about the association between socioeconomic status (SES) and EQ-5D-3L health utilities. Our objective was to examine EQ-5D-3L health utilities across SES in a real-world sample of patients with cancer. Methods: We conducted a cross-sectional analysis of EQ-5D-3L responses from 170 adult patients with cancer accrued from an Ontario oncology centre. We fitted multivariable linear regression models to estimate associations between covariates and EQ-5D-3L health utilities. Results: Lower EQ-5D-3L health utilities were significantly associated with the lowest and undisclosed family income categories in models with and without birth sex (p &lt; 0.05). In the model including birth sex, disutility estimates for lowest family income (&lt;CAD 29K) and undisclosed income was \u22120.202, 95% CI (\u22120.371 to \u22120.033), and \u22120.123 (\u22120.235 to \u22120.012), respectively. For the model excluding birth sex, disutility estimates for lowest income and undisclosed income was \u22120.163 (\u22120.280 to \u22120.046) and \u22120.106 (\u22120.184 to \u22120.028). Conclusions: Lower EQ-5D-3L health utilities were significantly associated with low income and nondisclosure, highlighting the need to incorporate SES in analyzing health utilities in cancer care.<\/jats:p>","DOI":"10.3390\/curroncol32110645","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:02:13Z","timestamp":1763546533000},"page":"645","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Examining the Association Between Equity-Related Factors and EQ-5D-3L Health Utilities of Patients with Cancer"],"prefix":"10.3390","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9806-9393","authenticated-orcid":false,"given":"Teresa C. O.","family":"Tsui","sequence":"first","affiliation":[{"name":"Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada"},{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5S 1A1, Canada"},{"name":"Canadian Centre for Applied Research in Cancer Control (ARCC), Toronto, ON M4N 3M5, Canada"},{"name":"Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9264-7797","authenticated-orcid":false,"given":"Rebecca E.","family":"Mercer","sequence":"additional","affiliation":[{"name":"Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada"},{"name":"Canadian Centre for Applied Research in Cancer Control (ARCC), Toronto, ON M4N 3M5, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4265-1330","authenticated-orcid":false,"given":"Eleanor M.","family":"Pullenayegum","sequence":"additional","affiliation":[{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5S 1A1, Canada"},{"name":"Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2501-3057","authenticated-orcid":false,"given":"Kelvin K. W.","family":"Chan","sequence":"additional","affiliation":[{"name":"Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada"},{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5S 1A1, Canada"},{"name":"Canadian Centre for Applied Research in Cancer Control (ARCC), Toronto, ON M4N 3M5, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"ref_1","first-page":"233","article-title":"Quality of life outcomes: Measurement and validation","volume":"10","author":"Cella","year":"1996","journal-title":"Oncology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"622","DOI":"10.7326\/0003-4819-118-8-199304150-00009","article-title":"Measuring health-related quality of life","volume":"118","author":"Guyatt","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1111\/j.1524-4733.2009.00515.x","article-title":"QALYs: The basics","volume":"12","author":"Weinstein","year":"2009","journal-title":"Value Health"},{"key":"ref_4","unstructured":"National Institute for Health and Care Excellence NICE Health Technology Evaluations: The Manual. Available online: https:\/\/www.nice.org.uk\/process\/pmg36\/resources\/nice-health-technology-evaluations-the-manual-pdf-72286779244741."},{"key":"ref_5","unstructured":"Canadian Agency for Drugs and Technologies in Health (2017). Guidelines for the Economic Evaluation of Health Technologies, Canadian Agency for Drugs and Technologies in Health."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/jamaoncol.2018.5953","article-title":"Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation","volume":"5","author":"Unger","year":"2019","journal-title":"JAMA Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jamaoncol.2015.3924","article-title":"Patient Income Level and Cancer Clinical Trial Participation: A Prospective Survey Study","volume":"2","author":"Unger","year":"2016","journal-title":"JAMA Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e6905","DOI":"10.1002\/cam4.6905","article-title":"Effects of socioeconomic status on enrollment in clinical trials for cancer: A systematic review","volume":"13","author":"Donzo","year":"2024","journal-title":"Cancer Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/0272989X15583266","article-title":"Distributional Cost-Effectiveness Analysis: A Tutorial","volume":"36","author":"Asaria","year":"2016","journal-title":"Med. Decis. Mak."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jval.2016.11.027","article-title":"Using Cost-Effectiveness Analysis to Address Health Equity Concerns","volume":"20","author":"Cookson","year":"2017","journal-title":"Value Health"},{"key":"ref_11","unstructured":"Drummond, M.F., Sculpher, M.J., Claxton, K., Stoddart, G.L., and Torrance, G.W. (2015). Methods for the Economic Evaluation of Health Care Programmes, Oxford University Press. [4th ed.]."},{"key":"ref_12","unstructured":"Dolan, P., Gudex, C., Kind, P., and Williams, A. (1995). A Social Tariff for EuroQol: Results from a UK General Population Survey, Centre for Health Economics, University of York."},{"key":"ref_13","unstructured":"EuroQol Foundation (2018). EQ-5D-3L User Guide, EuroQol Foundation."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual. Life Res."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Devlin, N., Parkin, D., and Janssen, B. (2020). Methods for Analysing and Reporting EQ-5D Data, Springer Nature.","DOI":"10.1007\/978-3-030-47622-9"},{"key":"ref_16","unstructured":"World Health Organization A Conceptual Framework for Action on the Social Determinants of Health. Social Determinants of Health Discussion Paper 2, Available online: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/ca294183-3263-470f-a5fe-8e124ec48c72\/content."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/jama.1995.03520250075037","article-title":"Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes","volume":"273","author":"Wilson","year":"1995","journal-title":"JAMA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40271-016-0190-z","article-title":"EQ-5D Health Utility Scores: Data from a Comprehensive Canadian Cancer Centre","volume":"10","author":"Naik","year":"2017","journal-title":"Patient"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e022711","DOI":"10.1136\/bmjopen-2018-022711","article-title":"Assessing health-related quality of life of patients with colorectal cancer using EQ-5D-5L: A cross-sectional study in Heilongjiang of China","volume":"8","author":"Huang","year":"2018","journal-title":"BMJ Open"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12955-024-02235-0","article-title":"Health inequity assessment in Brazil: Is EQ-5D-3L sensible enough to detect differences among distinct socioeconomic groups?","volume":"22","author":"Tura","year":"2024","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/bjc.2013.725","article-title":"Randomised controlled trials and population-based observational research: Partners in the evolution of medical evidence","volume":"110","author":"Booth","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Tsui, T.C.O., Mercer, R.E., Zhou, E.J., Desai, R.K., Chatterje, S., Yeung, C.Y.L., Pullenayegum, E.M., and Chan, K.K.W. (2025). Patient Experiences Regarding Feasibility of Implementing Real-World EQ-5D Collection at an Oncology Centre in Ontario, Canada. Curr. Oncol., 32.","DOI":"10.3390\/curroncol32060308"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s40271-023-00662-7","article-title":"A Review of the Use of EQ-5D for Clinical Outcome Assessment in Health Technology Assessment, Regulatory Claims, and Published Literature","volume":"17","author":"Shaw","year":"2024","journal-title":"Patient"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e733","DOI":"10.3747\/co.26.5297","article-title":"Combined cancer patient-reported symptom and health utility tool for routine clinical implementation: A real-world comparison of the ESAS and EQ-5D in multiple cancer sites","volume":"26","author":"Moskovitz","year":"2019","journal-title":"Curr. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Harrell, F.E. (2015). Regression Modeling Strategies, Springer Nature. [2nd ed.].","DOI":"10.1007\/978-3-319-19425-7"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.psych.59.103006.093735","article-title":"Sample size planning for statistical power and accuracy in parameter estimation","volume":"59","author":"Maxwell","year":"2008","journal-title":"Annu. Rev. Psychol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10198-018-0955-5","article-title":"Population norms for the EQ-5D-3L: A cross-country analysis of population surveys for 20 countries","volume":"20","author":"Janssen","year":"2019","journal-title":"Eur. J. Health Econ."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/jnci\/djac230","article-title":"Health-related quality of life by race, ethnicity, and country of origin among cancer survivors","volume":"115","author":"Reeve","year":"2023","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_29","unstructured":"Morton, F., and Nijjar, J. eq5d: Methods for Analysing \u2018EQ-5D\u2019 Data and Calculating \u2018EQ-5D\u2019 Index Scores. R package version 0.15.7. Available online: https:\/\/CRAN.R-project.org\/package=eq5d."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Bansback, N., Tsuchiya, A., Brazier, J., and Anis, A. (2012). Canadian valuation of EQ-5D health states: Preliminary value set and considerations for future valuation studies. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0031115"},{"key":"ref_31","unstructured":"Canadian Institute for Health Information Guidance on the Use of Standards for Race-Based and Indigenous Identity Data Collection and Health Reporting in Canada. Available online: https:\/\/www.cihi.ca\/sites\/default\/files\/document\/guidance-and-standards-for-race-based-and-indigenous-identity-data-en.pdf."},{"key":"ref_32","unstructured":"Canadian Cancer Society Canadian Cancer Statistics Dashboard. Available online: https:\/\/cancerstats.ca\/."},{"key":"ref_33","unstructured":"Statistics Canada Demographic Estimates by Age and Gender, Provinces and Territories: Interactive Dashboard. Available online: https:\/\/www150.statcan.gc.ca\/n1\/pub\/71-607-x\/71-607-x2020018-eng.htm."},{"key":"ref_34","unstructured":"Statistics Canada Focus on Geography Series, 2021 Census of Population. Available online: https:\/\/www12.statcan.gc.ca\/census-recensement\/2021\/as-sa\/fogs-spg\/page.cfm?topic=5&lang=E&dguid=2021A00053520005."},{"key":"ref_35","unstructured":"Statistics Canada Table 11-10-0192-01 Upper Income Limit, Income Share and Average Income by Economic Family Type and Income Decile. Available online: https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1110019201."},{"key":"ref_36","unstructured":"Canadian Cancer Society Canadian Cancer Statistics Advisory Committee in Collaboration with the Canadian Cancer Society, Statistics Canada and the Public Health Agency of Canada. Canadian Cancer Statistics: A 2024 Special Report on the Economic Impact of Cancer in Canada. Available online: https:\/\/cdn.cancer.ca\/-\/media\/files\/research\/cancer-statistics\/2024-statistics\/2024-special-report\/2024_pdf_en.pdf."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Kangwanrattanakul, K., and Krageloh, C.U. (2024). EQ-5D-3L and EQ-5D-5L population norms for Thailand. BMC Public Health, 24.","DOI":"10.1186\/s12889-024-18391-3"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12955-024-02323-1","article-title":"EQ-5D-5L population norms and health inequality for Trinidad and Tobago in 2022\u20132023 and comparison with 2012","volume":"22","author":"Bailey","year":"2024","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1586\/14737167.2016.1146594","article-title":"Is the EQ-5D suitable for use in oncology? An overview of the literature and recent developments","volume":"16","author":"Schwenkglenks","year":"2016","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Moradi, N., Poder, T.G., Safari, H., Mojahedian, M.M., and Ameri, H. (2022). Psychometric properties of the EQ-5D-5L compared with EQ-5D-3L in cancer patients in Iran. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.1052155"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jval.2022.06.011","article-title":"Distributional Cost-Effectiveness Analysis of Health Technologies: Data Requirements and Challenges","volume":"26","author":"Meunier","year":"2023","journal-title":"Value Health"}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/11\/645\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T05:17:11Z","timestamp":1763702231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/11\/645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":41,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["curroncol32110645"],"URL":"https:\/\/doi.org\/10.3390\/curroncol32110645","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]}}}